JSM 2013 Home
Online Program Home
My Program

Keyword Search

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Keyword Search Criteria: Biomarkers returned 22 record(s)
Sunday, 08/04/2013
LC-MRM-MS Data Analysis Strategy
Ming Li, VICC-Cancer Biostatistics Division
2:05 PM

Efficient Pooling Methods for Skewed Biomarker Data Subject to Regression Analysis
Emily Mitchell, Emory University; Robert H. Lyles, Emory University; Michelle Danaher, Eunice Kennedy Shriver National Institute of Child Health and Development; Neil J. Perkins, Eunice Kennedy Shriver National Institute of Child Health and Development; Enrique F. Schisterman, Eunice Kennedy Shriver National Institute of Child Health and Development
2:50 PM

Recent Development in Biomarker and Subgroup Identification for Tailored Therapeutics
Russell Wolfinger, SAS Institute Inc; Richard C. Zink, JMP Life Sciences, SAS Institute, Inc.
4:05 PM

A Resampling-based Ensemble Tree Method to Identify Patient Subgroups with Enhanced Treatment Effect
Chakib Battioui, Eli Lilly & Company; Lei Shen, Eli Lilly & Company; Stephen J. Ruberg, Eli Lilly & Company
4:25 PM

Bi-Level Groupwise Multiple Features Selection Method for Identifying Novel Biomarkers in Pharmacogenetic Studies
Ting-Huei Chen, UNC at Chapel Hill; Wei Sun, UNC Chapel Hill
4:35 PM

Determining Multimodal Biomarkers for Neurodegenerative Diseases
DuBois Bowman, Emory University; Wenqiong Xue, Emory University
5:05 PM

Estimating Biological Age Using Ensemble-Based Prediction Models
Wendy Shih; Steve Horvath, University of California, Los Angeles
5:20 PM

Monday, 08/05/2013
Patient-Reported Outcome and Biomarkers in Asthma
Wen-Hung Chen, United BioSource Corporation; Gary Globe, Amgen Inc.; Ingela Wiklund, United BioSource Corporation; Seppi Lin, Amgen Inc.; Michael Schatz, Kaiser Permanente Medical Center; Maria Mattera, United BioSource Corporation; Yun Chon, Amgen Inc.
8:55 AM

Nonlinear Mixed Effects Models to Study Determinants of Local Airway Inflammation Using Multiple Flow Exhaled Nitric Oxide Data
Sandrah Eckel, University of Southern California; Kiros Berhane, University of Southern California; Meng Liu, University of Southern California; Linn S William, University of Southern California; Muhammad T. Salam, University of Southern California; Edward B. Rappaport, University of Southern California; Frank D. Gilliland, University of Southern California
8:55 AM

Regression When the Predictor may be Censored
David Oakes, Univ of Rochester Medical Center
11:15 AM

Statistical Inference for Nonlinear Functional Models with Application to Copy Number Variation and Multiple Myeloma Data
Adrian Coles, North Carolina State University; Arnab Maity, North Carolina State University; Veera Baladandayuthapani, The University of Texas MD Anderson Cancer Center; Ganiraju Manyam, The University of Texas M.D. Anderson Cancer Center
2:20 PM

Tuesday, 08/06/2013
Survival-Related Prognostic Threshold on Quantitative Biomarkers
Xinhua Liu, Columbia University; Zhezhen Jin, Columbia University
8:55 AM

Using Incident Cases to Evaluate Prognostic Markers with Time-Varying Performance
Aasthaa Bansal, University of Washington; Patrick Heagerty, University of Washington
11:50 AM

Identifying Epigenomic Biomarkers for Anticancer Drug Responses by Integrating Gene Expression and DNA Methylation Profiles
Zhibao Mi, VA; Kui Shen, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh; Nan Song, the NSABP Foundation, Inc.
12:15 PM

Clinical Trial Designs for Biomarker Research in Oncology
Sumithra Mandrekar, Mayo Clinic
2:05 PM

Finding the Biologically Optimal Dose with Early Efficacy Biomarkers in Phase I Cancer Clinical Trials
Rui Qin, Mayo Clinic
2:25 PM

Identifying Subpopulations with Differential Risk Benefit Profiles
Tianxi Cai, Harvard University
3:20 PM

Wednesday, 08/07/2013
Calibration Problems with Panel Data Applied to Alzheimer's Disease Biomarkers
Huanli Wang, University of California, Davis; Danielle Harvey, UC Davis; Laurel Beckett, UC Davis


Comparative Effectiveness Research for Diagnostic Tests and Biomarkers
Constantine Gatsonis, Brown University
10:35 AM

Introduction to Joint Modeling of Longitudinal Biomarkers and Kidney Disease Outcomes
Tom Greene, University of Utah; Ken Boucher, University of Utah
2:05 PM

Time-Dependent ROC Analysis for Early Detection of End-Stage Renal Disease (ESRD) Using Baseline Glomerular Filtration Rate
Nan Hu, University of Utah
2:45 PM

Thursday, 08/08/2013
Sequential Testing of the Empirical Positive and Negative Predictive Value Curves with Unknown Prevalence
Joseph S. Koopmeiners, University of Minnesota; Ziding Feng, Fred Hutchinson Cancer Research Center
10:35 AM




2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.